Rimonabant for overweight and "metabolic syndrome": the attempt to supersize disease and risk by pharmaceutical marketing.
Banzi
Rita
R
Italian Cochrane Centre, Mario Negri Institute for Pharmacological Research, Via Eritrea 62, 20157 Milan, Italy.
Moja
Lorenzo
L
Moschetti
Ivan
I
Liberati
Alessandro
A
Gensini
Gian Franco
GF
Gusinu
Roberto
R
Conti
Andrea A
AA